Impaired Glucose Tolerance Clinical Trial
— S38Official title:
Effects of Dietary Protein Patterning on wt Loss and Resistance Training-induced Changes in Body Comp, Skeletal Muscle, and Indices of Metabolic Syndrome
Verified date | January 2017 |
Source | Purdue University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
About two-thirds of adults in the United States are overweight or obese with likely adverse health consequences. A Moderate weight loss by dieting and exercise is recommended to improve health. We are interested to know whether eating dietary protein at different times of the day influences changes in body composition, muscle and indices of health. The purpose of this study is to examine the effects of within-day patterning of dietary protein intake (even vs. skewed) on energy-restriction and resistance training-induced changes in body composition, muscle size, appetite, and clinical health (including blood glucose and blood pressure).
Status | Completed |
Enrollment | 41 |
Est. completion date | November 2015 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 50 Years |
Eligibility |
Inclusion Criteria: - non-smoking; - weight stable (± 4.5 kg during previous 3 months) - constant habitual activity patterns within last 3 months - no acute illness - not diabetic or have chronic diseases - blood profile within 10% of clinical normalcy - subjects not classified as high risk for cardiovascular disease - no use of medications - females who are not pregnant or lactating - ability to travel to testing and exercise training facilities - not claustrophobic and able to complete the muscle size testing using the magnetic resonance imager Exclusion Criteria: - Smoker - weight changed within 3 months - a history of disease or high risk of cardiovascular disease - history of claustrophobic - pregnant or lactating female |
Country | Name | City | State |
---|---|---|---|
United States | Purdue University | West Lafayette | Indiana |
Lead Sponsor | Collaborator |
---|---|
Purdue University | American Egg Board, Dairy Research Institute, National Cattlemen's Beef Association, National Pork Board |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Aerobic Fitness and Muscle Strength Assessment | An aerobic fitness will be assessed by submaximal aerobic capacity test and a maximal muscle strength will be examined using a one-repetition maximum test | 20 weeks | |
Primary | Body composition | Fasting-state body weight and waist and hip circumferences will be measured. Body composition (fat mass, lean body mass, and bone mass) will also be determined using Dual Energy X-ray Absorptiometry (DXA, GE Healthcare LUNAR iDXA™ with EnCORE software version 5.60, Madison, WI). | 20 weeks | |
Primary | Body composition | Fasting-state body weight and waist and hip circumferences will be measured. Body composition (fat mass, lean body mass, and bone mass) will also be determined using Dual Energy X-ray Absorptiometry | 20 weeks | |
Secondary | Whole body Imaging | A total of 2 magnetic resonance imaging (MRI) images of muscle and 1 MRI of the abdomen will be obtained | 20 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT04088461 -
Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine
|
Phase 4 | |
Completed |
NCT02621060 -
Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
|
Phase 2 | |
Completed |
NCT01521312 -
ACute and Chronic Effects of Saxagliptin
|
Phase 2 | |
Completed |
NCT01488279 -
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
|
N/A | |
Completed |
NCT01559896 -
Egg Protein Hydrolysate and Vascular Function
|
N/A | |
Completed |
NCT01030978 -
Prevention of Type 2 Diabetes in Children With a Family-based Healthy Lifestyle Program
|
N/A | |
Completed |
NCT00573781 -
Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism
|
Phase 2 | |
Terminated |
NCT00846521 -
Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity
|
Phase 4 | |
Completed |
NCT00241072 -
Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
|
Phase 4 | |
Completed |
NCT00536250 -
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
|
N/A | |
Completed |
NCT02254317 -
Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance
|
N/A | |
Completed |
NCT03764423 -
Health Effects of Salmon Fishmeal in Humans
|
N/A | |
Recruiting |
NCT05347030 -
Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population
|
N/A | |
Active, not recruiting |
NCT04341571 -
Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.
|
Phase 2 | |
Completed |
NCT02700334 -
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
|
Phase 4 | |
Active, not recruiting |
NCT01933529 -
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
|
Phase 2 | |
Completed |
NCT02135172 -
Breaks in Sedentary Time and Glucose Regulation in Women
|
N/A | |
Active, not recruiting |
NCT01841229 -
Effect of Ginseng on Glycemic Control
|
N/A | |
Completed |
NCT02248272 -
Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes
|
N/A |